Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers.

被引：1
|
作者：
Kris, Mark G. [1 ]
Offin, Michael David [1 ]
Feldman, Daniel L. [1 ]
Ni, Ai [1 ]
Lai, Wei-Chu Victoria [1 ]
Arbour, Kathryn Cecilia [1 ]
Daras, Mariza [1 ]
Pentsova, Elena [1 ]
DeAngelis, Lisa Marie [1 ]
Beal, Kathryn [1 ]
Young, Robert J. [1 ]
Jordan, Emmet [1 ]
Arcila, Maria E. [1 ]
Jones, David Randolph [1 ]
Isbell, James M. [1 ]
Riely, Gregory J. [1 ]
Drilon, Alexander E. [1 ]
Yu, Helena Alexandra [1 ]
Li, Bob T. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9081
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Analysis of primary and secondary EGFR-TKI resistance mutations evolution in 835 EGFR-mutant Chinese lung cancers.
    Dong, Xiaorong
    Zeng, Dongqiang
    Liu, Xinyi
    Huang, Mengli
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [22] HER kinase inhibition in patients with HER2- and HER3-mutant cancers
    David M. Hyman
    Sarina A. Piha-Paul
    Helen Won
    Jordi Rodon
    Cristina Saura
    Geoffrey I. Shapiro
    Dejan Juric
    David I. Quinn
    Victor Moreno
    Bernard Doger
    Ingrid A. Mayer
    Valentina Boni
    Emiliano Calvo
    Sherene Loi
    Albert C. Lockhart
    Joseph P. Erinjeri
    Maurizio Scaltriti
    Gary A. Ulaner
    Juber Patel
    Jiabin Tang
    Hannah Beer
    S. Duygu Selcuklu
    Aphrothiti J. Hanrahan
    Nancy Bouvier
    Myra Melcer
    Rajmohan Murali
    Alison M. Schram
    Lillian M. Smyth
    Komal Jhaveri
    Bob T. Li
    Alexander Drilon
    James J. Harding
    Gopa Iyer
    Barry S. Taylor
    Michael F. Berger
    Richard E. Cutler Jr
    Feng Xu
    Anna Butturini
    Lisa D. Eli
    Grace Mann
    Cynthia Farrell
    Alshad S. Lalani
    Richard P. Bryce
    Carlos L. Arteaga
    Funda Meric-Bernstam
    José Baselga
    David B. Solit
    [J]. Nature, 2018, 554 : 189 - 194
  • [23] Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases
    Yang, T. Jonathan
    Wu, Abraham J.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 134 - 137
  • [24] Considerations on the management of EGF receptor-TKIs for brain metastases in EGFR-mutant lung carcinoma patients
    Shingyoji, Masato
    Iuchi, Toshihiko
    [J]. LUNG CANCER MANAGEMENT, 2015, 4 (01) : 43 - 49
  • [25] Growth inhibition of KRAS- and EGFR-mutant lung adenocarcinoma by cosuppression of STAT3 and the SRC/ARHGAP35 axis
    Onodera, Ken
    Sakurada, Akira
    Notsuda, Hirotsugu
    Watanabe, Tatsuaki
    Matsuda, Yasushi
    Noda, Masafumi
    Endo, Chiaki
    Okada, Yoshinori
    [J]. ONCOLOGY REPORTS, 2018, 40 (03) : 1761 - 1768
  • [26] Treatment outcomes of EGFR-TKI with or without locoregional brain therapy in advanced EGFR-mutant non-small cell lung cancer patients with brain metastases
    Linh, Do Mai
    Thinh, Tran Huy
    Hieu, Nguyen-Van
    Duc, Nguyen Minh
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (02): : 71 - 79
  • [27] Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers.
    Schoenfeld, Adam Jacob
    Chan, Joseph Minhow
    Rizvi, Hira
    Rekhtman, Natasha
    Daneshbod, Yahya
    Kubota, Daisuke
    Chang, Jason C.
    Arcila, Maria E.
    Ladanyi, Marc
    Somwar, Romel
    Kris, Mark G.
    Pe'er, Dana
    Riely, Gregory J.
    Yu, Helena Alexandra
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers.
    Offin, Michael David
    Rizvi, Hira
    Tenet, Megan
    Ni, Ai
    Vega, Francisco Sanchez
    Kris, Mark G.
    Rudin, Charles M.
    Riely, Gregory J.
    Yu, Helena Alexandra
    Hellmann, Matthew David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers
    David M. Hyman
    Sarina A. Piha-Paul
    Helen Won
    Jordi Rodon
    Cristina Saura
    Geoffrey I. Shapiro
    Dejan Juric
    David I. Quinn
    Victor Moreno
    Bernard Doger
    Ingrid A. Mayer
    Valentina Boni
    Emiliano Calvo
    Sherene Loi
    Albert C. Lockhart
    Joseph P. Erinjeri
    Maurizio Scaltriti
    Gary A. Ulaner
    Juber Patel
    Jiabin Tang
    Hannah Beer
    S. Duygu Selcuklu
    Aphrothiti J. Hanrahan
    Nancy Bouvier
    Myra Melcer
    Rajmohan Murali
    Alison M. Schram
    Lillian M. Smyth
    Komal Jhaveri
    Bob T. Li
    Alexander Drilon
    James J. Harding
    Gopa Iyer
    Barry S. Taylor
    Michael F. Berger
    Richard E. Cutler
    Feng Xu
    Anna Butturini
    Lisa D. Eli
    Grace Mann
    Cynthia Farrell
    Alshad S. Lalani
    Richard P. Bryce
    Carlos L. Arteaga
    Funda Meric-Bernstam
    José Baselga
    David B. Solit
    [J]. Nature, 2019, 566 : E11 - E12
  • [30] Three Treatments for EGFR-Mutant Non-Small-Cell Lung Cancer with Brain Metastases
    Fan, Y.
    Yu, X.
    Wang, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2228 - S2228
12345